Embryo Transfer With Self-spent Culture Medium

Sponsor
Bin Wu (Other)
Overall Status
Completed
CT.gov ID
NCT03728140
Collaborator
(none)
335
1
2
24
14

Study Details

Study Description

Brief Summary

Embryo Transfer With Self-spent Culture Medium or new Culture Medium in Vitro Fertilization - Embryo Transfer Process, to analyze which way can improve clinical pregnancy outcomes, is there a significant difference between the two?

Condition or Disease Intervention/Treatment Phase
  • Procedure: Self-spent Culture Medium
N/A

Detailed Description

Although some metabolites are present in self-spent culture medium, there are some embryonic exocrine factors secreted by embryo.These factors may have a positive impact on embryo implantation and subsequent development. So it is necessary to compare the two ways of embryo transfer with Self-spent Culture Medium or New Culture Medium in vitro fertilization - embryo transfer process.

The purpose of this study is to analyze which way can improve clinical pregnancy and birth outcomes, is there a significant difference between the two?

Study Design

Study Type:
Interventional
Actual Enrollment :
335 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Screening
Official Title:
Can Embryo Transfer With Self-spent Culture Medium Improve Clinical Pregnancy Outcomes in Vitro Fertilization - Embryo Transfer Process?
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Self-spent Culture Medium

Changing embryo transfer solution with self-spent culture medium

Procedure: Self-spent Culture Medium
Replace embryo transfer solution with Self-spent culture medium in IVF-ET.

No Intervention: New Culture Medium

embryo transfer with new culture medium in IVF-ET

Outcome Measures

Primary Outcome Measures

  1. Number of Participants Pregnant After 4 Weeks [4 weeks]

    Observe the clinical pregnancy rate under different embryo transfer methods

  2. Live Birth [40 weeks]

    Observe the live birth rate under different embryo transfer methods

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 35 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Infertility female patients with tubal factors,

  • Infertile female patients with spouse factors

Exclusion Criteria:
  • Intrauterine adhesions,

  • Endometriosis,

  • Primary ovarian insufficiency,

  • Infectious disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jinan Central Hospital Affiliated to Shandong University Jinan Shandong China 250013

Sponsors and Collaborators

  • Bin Wu

Investigators

  • Study Director: Yingchun zhang, Dr, Jinan Central Hospital

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Bin Wu, Reproductive medcine, Jinan Central Hospital
ClinicalTrials.gov Identifier:
NCT03728140
Other Study ID Numbers:
  • JianCH-RM001
First Posted:
Nov 1, 2018
Last Update Posted:
Jan 27, 2020
Last Verified:
Dec 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bin Wu, Reproductive medcine, Jinan Central Hospital

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Self-spent Culture Medium New Culture Medium
Arm/Group Description Changing embryo transfer solution with self-spent culture medium Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET. embryo transfer with new culture medium in IVF-ET
Period Title: Overall Study
STARTED 160 175
COMPLETED 150 168
NOT COMPLETED 10 7

Baseline Characteristics

Arm/Group Title Self-spent Culture Medium New Culture Medium Total
Arm/Group Description Changing embryo transfer solution with self-spent culture medium Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET. embryo transfer with new culture medium in IVF-ET Total of all reporting groups
Overall Participants 150 168 318
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
30.31
(4.08)
29.72
(4.77)
29.99
(4.11)
Sex: Female, Male (Count of Participants)
Female
150
100%
168
100%
318
100%
Male
0
0%
0
0%
0
0%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Region of Enrollment (Count of Participants)
China
150
100%
168
100%
318
100%
duration of infertility (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
3.44
(2.24)
3.58
(3.39)
3.51
(2.97)

Outcome Measures

1. Primary Outcome
Title Number of Participants Pregnant After 4 Weeks
Description Observe the clinical pregnancy rate under different embryo transfer methods
Time Frame 4 weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Self-spent Culture Medium New Culture Medium
Arm/Group Description Changing embryo transfer solution with self-spent culture medium Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET. embryo transfer with new culture medium in IVF-ET
Measure Participants 150 168
Count of Participants [Participants]
85
56.7%
82
48.8%
2. Primary Outcome
Title Live Birth
Description Observe the live birth rate under different embryo transfer methods
Time Frame 40 weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Self-spent Culture Medium New Culture Medium
Arm/Group Description Changing embryo transfer solution with self-spent culture medium Self-spent Culture Medium: Replace embryo transfer solution with Self-spent culture medium in IVF-ET. embryo transfer with new culture medium in IVF-ET
Measure Participants 150 168
Count of Participants [Participants]
78
52%
74
44%

Adverse Events

Time Frame 1 year
Adverse Event Reporting Description No any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research,
Arm/Group Title Self-spent Culture Medium New Culture Medium
Arm/Group Description embryo transfer with self-spent culture medium embryo transfer with new culture medium
All Cause Mortality
Self-spent Culture Medium New Culture Medium
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/150 (0%) 0/168 (0%)
Serious Adverse Events
Self-spent Culture Medium New Culture Medium
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/150 (0%) 0/168 (0%)
Other (Not Including Serious) Adverse Events
Self-spent Culture Medium New Culture Medium
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/150 (0%) 0/168 (0%)

Limitations/Caveats

Studies of larger sample sizes and studies on some other variables were needed to be further performed.

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. bin wu
Organization Reproductive medcine of Jinan central hospatil
Phone +86 053185695203
Email wb0538@163.com
Responsible Party:
Bin Wu, Reproductive medcine, Jinan Central Hospital
ClinicalTrials.gov Identifier:
NCT03728140
Other Study ID Numbers:
  • JianCH-RM001
First Posted:
Nov 1, 2018
Last Update Posted:
Jan 27, 2020
Last Verified:
Dec 1, 2019